NCT07802340 Efficiency of Asiaticoside as Intracanal Medication in Revascularization Process
| NCT ID | NCT07802340 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mansoura University |
| Condition | Revascularization of Immature Young Permenant Teeth |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-09-15 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-09-15 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study assess the ability of Asiaticoside based Intracanal medication compared to the commonly used Intracanal medicament ( calcium hydroxide Ca(OH) 2) on the outcome of the revascularization process in immature teeth
Eligibility Criteria
Inclusion Criteria: * Both gender * patients having permanent anterior teeth with necrotic pulp and immature apex * Good general health * pulp space not needed for post and core Exclusion Criteria: * Radiographic identification of root fracture or abnormality * Uncooperative patients * Root resorption (internal or external)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07802340 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 18 Years, studying Revascularization of Immature Young Permenant Teeth. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07802340 currently recruiting?
Yes, NCT07802340 is actively recruiting participants. Contact the research team at Mahabaher23@gmail.com for enrollment information.
Where is the NCT07802340 trial being conducted?
This trial is being conducted at Al Mansurah, Egypt.
Who is sponsoring the NCT07802340 clinical trial?
NCT07802340 is sponsored by Mansoura University. The trial plans to enroll 20 participants.